Chemoinformaics analysis of Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl-, methylcarbamate
Molecular Weight | 277.408 | nRot | 1 |
Heavy Atom Molecular Weight | 250.192 | nRig | 7 |
Exact Molecular Weight | 277.204 | nRing | 1 |
Solubility: LogS | -4.853 | nHRing | 0 |
Solubility: LogP | 4.778 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 49.0974 |
nHD | 1 | BPOL | 30.2606 |
QED | 0.83 |
Synth | 2.404 |
Natural Product Likeliness | -0.08 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.736 |
Pgp-sub | 0.008 |
HIA | 0.947 |
CACO-2 | -5.133 |
MDCK | 0.0000114 |
BBB | 0.765 |
PPB | 0.974306 |
VDSS | 0.919 |
FU | 0.0577133 |
CYP1A2-inh | 0.899 |
CYP1A2-sub | 0.925 |
CYP2c19-inh | 0.812 |
CYP2c19-sub | 0.916 |
CYP2c9-inh | 0.573 |
CYP2c9-sub | 0.787 |
CYP2d6-inh | 0.757 |
CYP2d6-sub | 0.874 |
CYP3a4-inh | 0.66 |
CYP3a4-sub | 0.657 |
CL | 8.714 |
T12 | 0.388 |
hERG | 0.024 |
Ames | 0.009 |
ROA | 0.974 |
SkinSen | 0.577 |
Carcinogencity | 0.059 |
EI | 0.136 |
Respiratory | 0.932 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.617761 |